E
Elias K. Spanakis
Researcher at University of Maryland, Baltimore
Publications - 62
Citations - 2099
Elias K. Spanakis is an academic researcher from University of Maryland, Baltimore. The author has contributed to research in topics: Diabetes mellitus & Hypoglycemia. The author has an hindex of 19, co-authored 50 publications receiving 1533 citations. Previous affiliations of Elias K. Spanakis include Penn State Milton S. Hershey Medical Center & Johns Hopkins University School of Medicine.
Papers
More filters
Journal ArticleDOI
Race/Ethnic Difference in Diabetes and Diabetic Complications
TL;DR: Novel updates on race/ethnic differences in children and adults with type 1 diabetes, children with type 2 diabetes, and in Latino subpopulations are provided and biological, behavioral, social, environmental, and health system contributors to diabetes disparities are discussed to identify areas for future preventive interventions.
Journal ArticleDOI
Metabolic syndrome is common among middle-to-older aged Mediterranean patients with rheumatoid arthritis and correlates with disease activity: a retrospective, cross-sectional, controlled, study
Stylianos A Karvounaris,Prodromos Sidiropoulos,John A. Papadakis,Elias K. Spanakis,G. Bertsias,Herakles Kritikos,Emmanuel S. Ganotakis,Dimitrios T. Boumpas +7 more
TL;DR: The correlation of rheumatoid arthritis disease activity with MetS suggests that the increased prevalence of coronary heart disease in patients with rhearatoid arthritis may, at least in part, be attributed to the inflammatory burden of the disease.
Journal ArticleDOI
New Agents for the Treatment of Fungal Infections: Clinical Efficacy and Gaps in Coverage
TL;DR: Significant questions remain, including the management of breakthrough infections and treatment failures and the efficacy of the new antifungal agents against less common fungi.
Journal Article
Modest but sustained increase of serum high density lipoprotein cholesterol levels in patients with inflammatory arthritides treated with infliximab.
Elias K. Spanakis,Prodromos Sidiropoulos,John A. Papadakis,Emmanuel S. Ganotakis,George Katsikas,Stylianos A Karvounaris,Argyro Bizaki,H D Kritikos,Dimitrios T. Boumpas +8 more
TL;DR: Anti-TNF-a treatment in patients with chronic inflammatory arthritides induces a modest, but sustained, increase in serum HDL-C levels, which may have a favorable effect in reducing the cardiovascular risk in these patients.
Journal ArticleDOI
AVPR2 Variants and Mutations in Nephrogenic Diabetes Insipidus : Review and Missense Mutation Significance
TL;DR: Almost 90% of nephrogenic diabetes insipidus (NDI) is due to mutations in the arginine‐vasopressin receptor 2 gene (AVPR2), and the AVPR2 mutations are spread world‐wide.